Medical Care
Global Radioactive Medical Isotopes Market Research Report 2025
- Jan 17, 26
- ID: 676490
- Pages: 80
- Figures: 79
- Views: 8
This report aims to provide a comprehensive presentation of the global market for Radioactive Medical Isotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioactive Medical Isotopes.
The Radioactive Medical Isotopes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radioactive Medical Isotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radioactive Medical Isotopes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
China National Nuclear Corporation (CNNC)
IRE ELIT
Nordion
Polatom
Segment by Type
Carbon-14
Technetium-99m
Iodine-131
Iodine-125
Others
Segment by Application
Diagnosis
Treatment
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioactive Medical Isotopes company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Radioactive Medical Isotopes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radioactive Medical Isotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radioactive Medical Isotopes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
China National Nuclear Corporation (CNNC)
IRE ELIT
Nordion
Polatom
Segment by Type
Carbon-14
Technetium-99m
Iodine-131
Iodine-125
Others
Segment by Application
Diagnosis
Treatment
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioactive Medical Isotopes company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioactive Medical Isotopes Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Carbon-14
1.2.3 Technetium-99m
1.2.4 Iodine-131
1.2.5 Iodine-125
1.2.6 Others
1.3 Market by Application
1.3.1 Global Radioactive Medical Isotopes Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnosis
1.3.3 Treatment
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radioactive Medical Isotopes Market Perspective (2020-2031)
2.2 Global Radioactive Medical Isotopes Growth Trends by Region
2.2.1 Global Radioactive Medical Isotopes Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radioactive Medical Isotopes Historic Market Size by Region (2020-2025)
2.2.3 Radioactive Medical Isotopes Forecasted Market Size by Region (2026-2031)
2.3 Radioactive Medical Isotopes Market Dynamics
2.3.1 Radioactive Medical Isotopes Industry Trends
2.3.2 Radioactive Medical Isotopes Market Drivers
2.3.3 Radioactive Medical Isotopes Market Challenges
2.3.4 Radioactive Medical Isotopes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radioactive Medical Isotopes Players by Revenue
3.1.1 Global Top Radioactive Medical Isotopes Players by Revenue (2020-2025)
3.1.2 Global Radioactive Medical Isotopes Revenue Market Share by Players (2020-2025)
3.2 Global Radioactive Medical Isotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radioactive Medical Isotopes Revenue
3.4 Global Radioactive Medical Isotopes Market Concentration Ratio
3.4.1 Global Radioactive Medical Isotopes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioactive Medical Isotopes Revenue in 2024
3.5 Global Key Players of Radioactive Medical Isotopes Head office and Area Served
3.6 Global Key Players of Radioactive Medical Isotopes, Product and Application
3.7 Global Key Players of Radioactive Medical Isotopes, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radioactive Medical Isotopes Breakdown Data by Type
4.1 Global Radioactive Medical Isotopes Historic Market Size by Type (2020-2025)
4.2 Global Radioactive Medical Isotopes Forecasted Market Size by Type (2026-2031)
5 Radioactive Medical Isotopes Breakdown Data by Application
5.1 Global Radioactive Medical Isotopes Historic Market Size by Application (2020-2025)
5.2 Global Radioactive Medical Isotopes Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radioactive Medical Isotopes Market Size (2020-2031)
6.2 North America Radioactive Medical Isotopes Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radioactive Medical Isotopes Market Size by Country (2020-2025)
6.4 North America Radioactive Medical Isotopes Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radioactive Medical Isotopes Market Size (2020-2031)
7.2 Europe Radioactive Medical Isotopes Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radioactive Medical Isotopes Market Size by Country (2020-2025)
7.4 Europe Radioactive Medical Isotopes Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radioactive Medical Isotopes Market Size (2020-2031)
8.2 Asia-Pacific Radioactive Medical Isotopes Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radioactive Medical Isotopes Market Size by Region (2020-2025)
8.4 Asia-Pacific Radioactive Medical Isotopes Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radioactive Medical Isotopes Market Size (2020-2031)
9.2 Latin America Radioactive Medical Isotopes Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radioactive Medical Isotopes Market Size by Country (2020-2025)
9.4 Latin America Radioactive Medical Isotopes Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radioactive Medical Isotopes Market Size (2020-2031)
10.2 Middle East & Africa Radioactive Medical Isotopes Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radioactive Medical Isotopes Market Size by Country (2020-2025)
10.4 Middle East & Africa Radioactive Medical Isotopes Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NRG
11.1.1 NRG Company Details
11.1.2 NRG Business Overview
11.1.3 NRG Radioactive Medical Isotopes Introduction
11.1.4 NRG Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.1.5 NRG Recent Development
11.2 NTP Radioisotopes
11.2.1 NTP Radioisotopes Company Details
11.2.2 NTP Radioisotopes Business Overview
11.2.3 NTP Radioisotopes Radioactive Medical Isotopes Introduction
11.2.4 NTP Radioisotopes Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.2.5 NTP Radioisotopes Recent Development
11.3 JSC Isotope
11.3.1 JSC Isotope Company Details
11.3.2 JSC Isotope Business Overview
11.3.3 JSC Isotope Radioactive Medical Isotopes Introduction
11.3.4 JSC Isotope Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.3.5 JSC Isotope Recent Development
11.4 ANSTO
11.4.1 ANSTO Company Details
11.4.2 ANSTO Business Overview
11.4.3 ANSTO Radioactive Medical Isotopes Introduction
11.4.4 ANSTO Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.4.5 ANSTO Recent Development
11.5 China National Nuclear Corporation (CNNC)
11.5.1 China National Nuclear Corporation (CNNC) Company Details
11.5.2 China National Nuclear Corporation (CNNC) Business Overview
11.5.3 China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Introduction
11.5.4 China National Nuclear Corporation (CNNC) Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.5.5 China National Nuclear Corporation (CNNC) Recent Development
11.6 IRE ELIT
11.6.1 IRE ELIT Company Details
11.6.2 IRE ELIT Business Overview
11.6.3 IRE ELIT Radioactive Medical Isotopes Introduction
11.6.4 IRE ELIT Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.6.5 IRE ELIT Recent Development
11.7 Nordion
11.7.1 Nordion Company Details
11.7.2 Nordion Business Overview
11.7.3 Nordion Radioactive Medical Isotopes Introduction
11.7.4 Nordion Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.7.5 Nordion Recent Development
11.8 Polatom
11.8.1 Polatom Company Details
11.8.2 Polatom Business Overview
11.8.3 Polatom Radioactive Medical Isotopes Introduction
11.8.4 Polatom Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.8.5 Polatom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioactive Medical Isotopes Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Carbon-14
1.2.3 Technetium-99m
1.2.4 Iodine-131
1.2.5 Iodine-125
1.2.6 Others
1.3 Market by Application
1.3.1 Global Radioactive Medical Isotopes Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnosis
1.3.3 Treatment
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radioactive Medical Isotopes Market Perspective (2020-2031)
2.2 Global Radioactive Medical Isotopes Growth Trends by Region
2.2.1 Global Radioactive Medical Isotopes Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radioactive Medical Isotopes Historic Market Size by Region (2020-2025)
2.2.3 Radioactive Medical Isotopes Forecasted Market Size by Region (2026-2031)
2.3 Radioactive Medical Isotopes Market Dynamics
2.3.1 Radioactive Medical Isotopes Industry Trends
2.3.2 Radioactive Medical Isotopes Market Drivers
2.3.3 Radioactive Medical Isotopes Market Challenges
2.3.4 Radioactive Medical Isotopes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radioactive Medical Isotopes Players by Revenue
3.1.1 Global Top Radioactive Medical Isotopes Players by Revenue (2020-2025)
3.1.2 Global Radioactive Medical Isotopes Revenue Market Share by Players (2020-2025)
3.2 Global Radioactive Medical Isotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radioactive Medical Isotopes Revenue
3.4 Global Radioactive Medical Isotopes Market Concentration Ratio
3.4.1 Global Radioactive Medical Isotopes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioactive Medical Isotopes Revenue in 2024
3.5 Global Key Players of Radioactive Medical Isotopes Head office and Area Served
3.6 Global Key Players of Radioactive Medical Isotopes, Product and Application
3.7 Global Key Players of Radioactive Medical Isotopes, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radioactive Medical Isotopes Breakdown Data by Type
4.1 Global Radioactive Medical Isotopes Historic Market Size by Type (2020-2025)
4.2 Global Radioactive Medical Isotopes Forecasted Market Size by Type (2026-2031)
5 Radioactive Medical Isotopes Breakdown Data by Application
5.1 Global Radioactive Medical Isotopes Historic Market Size by Application (2020-2025)
5.2 Global Radioactive Medical Isotopes Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radioactive Medical Isotopes Market Size (2020-2031)
6.2 North America Radioactive Medical Isotopes Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radioactive Medical Isotopes Market Size by Country (2020-2025)
6.4 North America Radioactive Medical Isotopes Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radioactive Medical Isotopes Market Size (2020-2031)
7.2 Europe Radioactive Medical Isotopes Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radioactive Medical Isotopes Market Size by Country (2020-2025)
7.4 Europe Radioactive Medical Isotopes Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radioactive Medical Isotopes Market Size (2020-2031)
8.2 Asia-Pacific Radioactive Medical Isotopes Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radioactive Medical Isotopes Market Size by Region (2020-2025)
8.4 Asia-Pacific Radioactive Medical Isotopes Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radioactive Medical Isotopes Market Size (2020-2031)
9.2 Latin America Radioactive Medical Isotopes Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radioactive Medical Isotopes Market Size by Country (2020-2025)
9.4 Latin America Radioactive Medical Isotopes Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radioactive Medical Isotopes Market Size (2020-2031)
10.2 Middle East & Africa Radioactive Medical Isotopes Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radioactive Medical Isotopes Market Size by Country (2020-2025)
10.4 Middle East & Africa Radioactive Medical Isotopes Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NRG
11.1.1 NRG Company Details
11.1.2 NRG Business Overview
11.1.3 NRG Radioactive Medical Isotopes Introduction
11.1.4 NRG Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.1.5 NRG Recent Development
11.2 NTP Radioisotopes
11.2.1 NTP Radioisotopes Company Details
11.2.2 NTP Radioisotopes Business Overview
11.2.3 NTP Radioisotopes Radioactive Medical Isotopes Introduction
11.2.4 NTP Radioisotopes Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.2.5 NTP Radioisotopes Recent Development
11.3 JSC Isotope
11.3.1 JSC Isotope Company Details
11.3.2 JSC Isotope Business Overview
11.3.3 JSC Isotope Radioactive Medical Isotopes Introduction
11.3.4 JSC Isotope Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.3.5 JSC Isotope Recent Development
11.4 ANSTO
11.4.1 ANSTO Company Details
11.4.2 ANSTO Business Overview
11.4.3 ANSTO Radioactive Medical Isotopes Introduction
11.4.4 ANSTO Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.4.5 ANSTO Recent Development
11.5 China National Nuclear Corporation (CNNC)
11.5.1 China National Nuclear Corporation (CNNC) Company Details
11.5.2 China National Nuclear Corporation (CNNC) Business Overview
11.5.3 China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Introduction
11.5.4 China National Nuclear Corporation (CNNC) Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.5.5 China National Nuclear Corporation (CNNC) Recent Development
11.6 IRE ELIT
11.6.1 IRE ELIT Company Details
11.6.2 IRE ELIT Business Overview
11.6.3 IRE ELIT Radioactive Medical Isotopes Introduction
11.6.4 IRE ELIT Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.6.5 IRE ELIT Recent Development
11.7 Nordion
11.7.1 Nordion Company Details
11.7.2 Nordion Business Overview
11.7.3 Nordion Radioactive Medical Isotopes Introduction
11.7.4 Nordion Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.7.5 Nordion Recent Development
11.8 Polatom
11.8.1 Polatom Company Details
11.8.2 Polatom Business Overview
11.8.3 Polatom Radioactive Medical Isotopes Introduction
11.8.4 Polatom Revenue in Radioactive Medical Isotopes Business (2020-2025)
11.8.5 Polatom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Radioactive Medical Isotopes Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Carbon-14
Table 3. Key Players of Technetium-99m
Table 4. Key Players of Iodine-131
Table 5. Key Players of Iodine-125
Table 6. Key Players of Others
Table 7. Global Radioactive Medical Isotopes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Radioactive Medical Isotopes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Radioactive Medical Isotopes Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Radioactive Medical Isotopes Market Share by Region (2020-2025)
Table 11. Global Radioactive Medical Isotopes Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Radioactive Medical Isotopes Market Share by Region (2026-2031)
Table 13. Radioactive Medical Isotopes Market Trends
Table 14. Radioactive Medical Isotopes Market Drivers
Table 15. Radioactive Medical Isotopes Market Challenges
Table 16. Radioactive Medical Isotopes Market Restraints
Table 17. Global Radioactive Medical Isotopes Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Radioactive Medical Isotopes Market Share by Players (2020-2025)
Table 19. Global Top Radioactive Medical Isotopes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioactive Medical Isotopes as of 2024)
Table 20. Ranking of Global Top Radioactive Medical Isotopes Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Radioactive Medical Isotopes Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Radioactive Medical Isotopes, Headquarters and Area Served
Table 23. Global Key Players of Radioactive Medical Isotopes, Product and Application
Table 24. Global Key Players of Radioactive Medical Isotopes, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Radioactive Medical Isotopes Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Radioactive Medical Isotopes Revenue Market Share by Type (2020-2025)
Table 28. Global Radioactive Medical Isotopes Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Radioactive Medical Isotopes Revenue Market Share by Type (2026-2031)
Table 30. Global Radioactive Medical Isotopes Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Radioactive Medical Isotopes Revenue Market Share by Application (2020-2025)
Table 32. Global Radioactive Medical Isotopes Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Radioactive Medical Isotopes Revenue Market Share by Application (2026-2031)
Table 34. North America Radioactive Medical Isotopes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Radioactive Medical Isotopes Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Radioactive Medical Isotopes Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Radioactive Medical Isotopes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Radioactive Medical Isotopes Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Radioactive Medical Isotopes Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Radioactive Medical Isotopes Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Radioactive Medical Isotopes Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Radioactive Medical Isotopes Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Radioactive Medical Isotopes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Radioactive Medical Isotopes Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Radioactive Medical Isotopes Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Radioactive Medical Isotopes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Radioactive Medical Isotopes Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Radioactive Medical Isotopes Market Size by Country (2026-2031) & (US$ Million)
Table 49. NRG Company Details
Table 50. NRG Business Overview
Table 51. NRG Radioactive Medical Isotopes Product
Table 52. NRG Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 53. NRG Recent Development
Table 54. NTP Radioisotopes Company Details
Table 55. NTP Radioisotopes Business Overview
Table 56. NTP Radioisotopes Radioactive Medical Isotopes Product
Table 57. NTP Radioisotopes Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 58. NTP Radioisotopes Recent Development
Table 59. JSC Isotope Company Details
Table 60. JSC Isotope Business Overview
Table 61. JSC Isotope Radioactive Medical Isotopes Product
Table 62. JSC Isotope Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 63. JSC Isotope Recent Development
Table 64. ANSTO Company Details
Table 65. ANSTO Business Overview
Table 66. ANSTO Radioactive Medical Isotopes Product
Table 67. ANSTO Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 68. ANSTO Recent Development
Table 69. China National Nuclear Corporation (CNNC) Company Details
Table 70. China National Nuclear Corporation (CNNC) Business Overview
Table 71. China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Product
Table 72. China National Nuclear Corporation (CNNC) Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 73. China National Nuclear Corporation (CNNC) Recent Development
Table 74. IRE ELIT Company Details
Table 75. IRE ELIT Business Overview
Table 76. IRE ELIT Radioactive Medical Isotopes Product
Table 77. IRE ELIT Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 78. IRE ELIT Recent Development
Table 79. Nordion Company Details
Table 80. Nordion Business Overview
Table 81. Nordion Radioactive Medical Isotopes Product
Table 82. Nordion Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 83. Nordion Recent Development
Table 84. Polatom Company Details
Table 85. Polatom Business Overview
Table 86. Polatom Radioactive Medical Isotopes Product
Table 87. Polatom Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 88. Polatom Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. Radioactive Medical Isotopes Picture
Figure 2. Global Radioactive Medical Isotopes Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radioactive Medical Isotopes Market Share by Type: 2024 VS 2031
Figure 4. Carbon-14 Features
Figure 5. Technetium-99m Features
Figure 6. Iodine-131 Features
Figure 7. Iodine-125 Features
Figure 8. Others Features
Figure 9. Global Radioactive Medical Isotopes Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Radioactive Medical Isotopes Market Share by Application: 2024 VS 2031
Figure 11. Diagnosis Case Studies
Figure 12. Treatment Case Studies
Figure 13. Others Case Studies
Figure 14. Radioactive Medical Isotopes Report Years Considered
Figure 15. Global Radioactive Medical Isotopes Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Radioactive Medical Isotopes Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Radioactive Medical Isotopes Market Share by Region: 2024 VS 2031
Figure 18. Global Radioactive Medical Isotopes Market Share by Players in 2024
Figure 19. Global Top Radioactive Medical Isotopes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioactive Medical Isotopes as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Radioactive Medical Isotopes Revenue in 2024
Figure 21. North America Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Radioactive Medical Isotopes Market Share by Country (2020-2031)
Figure 23. United States Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Radioactive Medical Isotopes Market Share by Country (2020-2031)
Figure 27. Germany Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Radioactive Medical Isotopes Market Share by Region (2020-2031)
Figure 35. China Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Radioactive Medical Isotopes Market Share by Country (2020-2031)
Figure 43. Mexico Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Radioactive Medical Isotopes Market Share by Country (2020-2031)
Figure 47. Turkey Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. NRG Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 51. NTP Radioisotopes Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 52. JSC Isotope Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 53. ANSTO Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 54. China National Nuclear Corporation (CNNC) Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 55. IRE ELIT Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 56. Nordion Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 57. Polatom Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Radioactive Medical Isotopes Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Carbon-14
Table 3. Key Players of Technetium-99m
Table 4. Key Players of Iodine-131
Table 5. Key Players of Iodine-125
Table 6. Key Players of Others
Table 7. Global Radioactive Medical Isotopes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Radioactive Medical Isotopes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Radioactive Medical Isotopes Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Radioactive Medical Isotopes Market Share by Region (2020-2025)
Table 11. Global Radioactive Medical Isotopes Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Radioactive Medical Isotopes Market Share by Region (2026-2031)
Table 13. Radioactive Medical Isotopes Market Trends
Table 14. Radioactive Medical Isotopes Market Drivers
Table 15. Radioactive Medical Isotopes Market Challenges
Table 16. Radioactive Medical Isotopes Market Restraints
Table 17. Global Radioactive Medical Isotopes Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Radioactive Medical Isotopes Market Share by Players (2020-2025)
Table 19. Global Top Radioactive Medical Isotopes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioactive Medical Isotopes as of 2024)
Table 20. Ranking of Global Top Radioactive Medical Isotopes Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Radioactive Medical Isotopes Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Radioactive Medical Isotopes, Headquarters and Area Served
Table 23. Global Key Players of Radioactive Medical Isotopes, Product and Application
Table 24. Global Key Players of Radioactive Medical Isotopes, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Radioactive Medical Isotopes Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Radioactive Medical Isotopes Revenue Market Share by Type (2020-2025)
Table 28. Global Radioactive Medical Isotopes Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Radioactive Medical Isotopes Revenue Market Share by Type (2026-2031)
Table 30. Global Radioactive Medical Isotopes Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Radioactive Medical Isotopes Revenue Market Share by Application (2020-2025)
Table 32. Global Radioactive Medical Isotopes Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Radioactive Medical Isotopes Revenue Market Share by Application (2026-2031)
Table 34. North America Radioactive Medical Isotopes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Radioactive Medical Isotopes Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Radioactive Medical Isotopes Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Radioactive Medical Isotopes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Radioactive Medical Isotopes Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Radioactive Medical Isotopes Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Radioactive Medical Isotopes Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Radioactive Medical Isotopes Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Radioactive Medical Isotopes Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Radioactive Medical Isotopes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Radioactive Medical Isotopes Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Radioactive Medical Isotopes Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Radioactive Medical Isotopes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Radioactive Medical Isotopes Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Radioactive Medical Isotopes Market Size by Country (2026-2031) & (US$ Million)
Table 49. NRG Company Details
Table 50. NRG Business Overview
Table 51. NRG Radioactive Medical Isotopes Product
Table 52. NRG Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 53. NRG Recent Development
Table 54. NTP Radioisotopes Company Details
Table 55. NTP Radioisotopes Business Overview
Table 56. NTP Radioisotopes Radioactive Medical Isotopes Product
Table 57. NTP Radioisotopes Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 58. NTP Radioisotopes Recent Development
Table 59. JSC Isotope Company Details
Table 60. JSC Isotope Business Overview
Table 61. JSC Isotope Radioactive Medical Isotopes Product
Table 62. JSC Isotope Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 63. JSC Isotope Recent Development
Table 64. ANSTO Company Details
Table 65. ANSTO Business Overview
Table 66. ANSTO Radioactive Medical Isotopes Product
Table 67. ANSTO Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 68. ANSTO Recent Development
Table 69. China National Nuclear Corporation (CNNC) Company Details
Table 70. China National Nuclear Corporation (CNNC) Business Overview
Table 71. China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Product
Table 72. China National Nuclear Corporation (CNNC) Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 73. China National Nuclear Corporation (CNNC) Recent Development
Table 74. IRE ELIT Company Details
Table 75. IRE ELIT Business Overview
Table 76. IRE ELIT Radioactive Medical Isotopes Product
Table 77. IRE ELIT Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 78. IRE ELIT Recent Development
Table 79. Nordion Company Details
Table 80. Nordion Business Overview
Table 81. Nordion Radioactive Medical Isotopes Product
Table 82. Nordion Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 83. Nordion Recent Development
Table 84. Polatom Company Details
Table 85. Polatom Business Overview
Table 86. Polatom Radioactive Medical Isotopes Product
Table 87. Polatom Revenue in Radioactive Medical Isotopes Business (2020-2025) & (US$ Million)
Table 88. Polatom Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. Radioactive Medical Isotopes Picture
Figure 2. Global Radioactive Medical Isotopes Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radioactive Medical Isotopes Market Share by Type: 2024 VS 2031
Figure 4. Carbon-14 Features
Figure 5. Technetium-99m Features
Figure 6. Iodine-131 Features
Figure 7. Iodine-125 Features
Figure 8. Others Features
Figure 9. Global Radioactive Medical Isotopes Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Radioactive Medical Isotopes Market Share by Application: 2024 VS 2031
Figure 11. Diagnosis Case Studies
Figure 12. Treatment Case Studies
Figure 13. Others Case Studies
Figure 14. Radioactive Medical Isotopes Report Years Considered
Figure 15. Global Radioactive Medical Isotopes Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Radioactive Medical Isotopes Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Radioactive Medical Isotopes Market Share by Region: 2024 VS 2031
Figure 18. Global Radioactive Medical Isotopes Market Share by Players in 2024
Figure 19. Global Top Radioactive Medical Isotopes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioactive Medical Isotopes as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Radioactive Medical Isotopes Revenue in 2024
Figure 21. North America Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Radioactive Medical Isotopes Market Share by Country (2020-2031)
Figure 23. United States Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Radioactive Medical Isotopes Market Share by Country (2020-2031)
Figure 27. Germany Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Radioactive Medical Isotopes Market Share by Region (2020-2031)
Figure 35. China Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Radioactive Medical Isotopes Market Share by Country (2020-2031)
Figure 43. Mexico Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Radioactive Medical Isotopes Market Share by Country (2020-2031)
Figure 47. Turkey Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Radioactive Medical Isotopes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. NRG Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 51. NTP Radioisotopes Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 52. JSC Isotope Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 53. ANSTO Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 54. China National Nuclear Corporation (CNNC) Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 55. IRE ELIT Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 56. Nordion Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 57. Polatom Revenue Growth Rate in Radioactive Medical Isotopes Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232